摘要
本文揭示一種用以治療因嗜中性白血球活化及趨化失調所致相關疾病的方法。該方法包括向有此需要的個體投予有效量的台灣白及萃取物,其至少包含3,3’-二羥基-5-甲氧聯苄基(山藥素III),9,10-二氫-1-[(4-羥苯基)甲基]-4-甲氧基-2,7-菲二醇(Orchidble),3',5-二甲氧基-3-羥聯苄基(BF8-4-2),3,5-二甲氧基-3'-羥聯苄基(BF8-4-3)和3-羥基-5-甲氧基聯苄基(BF8-4-4)。
貢獻的翻譯標題 | USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS |
---|---|
原文 | 繁體中文 |
IPC | A61K 36/898(2006.01); A61K 31/085(2006.01); A61P 1/16(2006.01); A61P 11/00(2006.01); A61P 17/06(2006.01) |
出版狀態 | 已出版 - 01 12 2024 |
文獻附註
公開公告號: 2.02446414E8Announcement ID: 2.02446414E8
Keywords
- or disorders associated with the dysregulated activation and recruitment of neutrophils. The method includes administering to a subject in need thereof an effective amount of an extract of Bletilla formosana.The Bletilla formosanaextract includes, at least, compounds of 3,3’-dihydroxy-5-methoxybibenzyl (Batatacin III), 9,10-dihydro-1-[(4-hydroxyphenyl)methyl]-4-methoxy-2,7-phenanthrenediol (Orchidble), 3',5-dimethoxy-3-hydroxybibenzyl (BF8-4-2), 3,5-dimethoxy-3'-hydroxybibenzyl (BF8-4-3) and 3-hydroxy-5-methoxybibenzyl (BF8-4-4).